Clinical Services

Long-lasting infection-control solution now available in Australia

12 February, 2021

SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices.


Vaccine rollout may face delays

11 February, 2021 by Amy Sarcevic

Insufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.


Russian Sputnik vaccine demonstrates 91.6% efficacy

08 February, 2021

Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19.


Aus biotech company supplies at-home COVID-19 tests to US

05 February, 2021 by Lauren Davis

Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.


Active ingredient prescribing comes into effect

04 February, 2021 by Matthew Grant, Monash University

Doctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.


Novavax vaccine demonstrates 89.3% efficacy

03 February, 2021

Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.


ANPC develops new COVID-19-detecting technology

03 February, 2021

A patent has been filed for advanced magnetic resonance technology that can detect the pathological signature of COVID-19 without relying on direct detection of the SARS-CoV-2 virus.


Blood cancer burden on the rise

03 February, 2021

Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation.


COVID-19 may reduce male fertility

01 February, 2021

A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility.


Monash innovation reduces risk of COVID in healthcare workers

29 January, 2021

A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.


Hospital pharmacists prepare for vaccine rollout

27 January, 2021

With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.


Study predicts global cancer surgery surge

27 January, 2021

A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.


Immunotherapy trial holds hope for children needing stem cell transplants

26 January, 2021

A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.


TGA approves Pfizer/BioNTech vaccine

25 January, 2021

The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.


How soon will we reach herd immunity for COVID-19?

25 January, 2021 by Amy Sarcevic

Achieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd